NCT00092274View on ClinicalTrials.gov

Study of HuMax-CD20, a New Drug to Treat Early Stage Non-Hodgkin´s Follicular Lymphoma

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2004

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions
Lymphoma, Follicular
Interventions
DRUG

HuMax-CD20

Trial Locations (1)

52242

University of Iowa Hospitals and Clinics, Iowa City

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY